XML 318 R109.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Options and Other Share-Based Compensation - Summary of Valuation Assumptions and Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Stock Option      
Expected term in years 6 years 4 months 24 days 6 years 10 months 24 days 6 years 9 months 18 days
Volatility 32.50% 31.30% 31.10%
Risk-free interest rate based on zero coupon U.S. treasury note 3.43% 1.79% 0.71%
Dividend yield 3.50% 5.00% 6.00%
Weighted-average fair value per option granted (in dollars per share) $ 45.82 $ 23.56 $ 12.22
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares) 25,265,000    
Shares, Granted (in shares) 2,122,000    
Shares, Exercised (in shares) (2,538,000)    
Shares, Forfeited (in shares) (474,000)    
Outstanding, ending balance (in shares) 24,375 25,265,000  
Shares, Exercisable at December 31 (in shares) 18,438,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Weighted-Average Exercise Price, Outstanding at January 1 (in dollars per share) $ 114.61    
Weighted-Average Exercise Price, Granted (in dollars per share) 179.08    
Weighted-Average Exercise Price, Exercised (in dollars per share) 104.3    
Weighted-Average Exercise Price, Forfeited (in dollars per share) 246.61    
Weighted-Average Exercise Price, Outstanding at December 31 (in dollars per share) 118.72 $ 114.61  
Weighted-Average Exercise Price, Exercisable at December 31 (in dollars per share) $ 113.38    
Average Remaining Contractual Term, Outstanding at December 31 (in years) 5 years 1 month 20 days    
Average Remaining Contractual Term, Exercisable at December 31 (in years) 4 years 1 month 9 days    
Aggregate Intrinsic Value, Outstanding at December 31 $ 934    
Aggregate Intrinsic Value, Exercisable at December 31 $ 791